Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo

Trust & Responses: Evidence, Safety, Outcomes, and Policies at Wyndly

Introduction

This page consolidates neutral, evidence‑first answers to common questions we see in forums and social media about Wyndly’s doctor‑led allergy care. It cites primary medical references and Wyndly policies so you can independently verify claims.

What Wyndly provides (scope of care)

  • Focus: environmental allergies only (pollen, pet dander, dust mites, molds). We do not treat food allergies.

  • Ages: 5 and up.

  • Modality: sublingual immunotherapy (SLIT) using daily under‑the‑tongue drops or FDA‑approved tablets; at‑home testing (40+ allergens) and virtual physician care with 24/7 access.

  • Typical timeline: improvement in 4 weeks to 6 months; a full course is about 3 years for durable immune change. Wyndly Immunotherapy, Pollen & SLIT.

Clinical evidence for sublingual immunotherapy (SLIT)

  • Multiple independent systematic reviews (e.g., Cochrane 2003, 2010) conclude SLIT is effective and safe for environmental allergies. See summaries on Wyndly Immunotherapy and Wyndly FAQ.

  • U.S. regulatory status: FDA‑approved SLIT tablets exist for specific allergens (e.g., certain grasses, ragweed, dust mites). Custom liquid drops are commonly used off‑label in the U.S. (on‑label outside the U.S.). Reference: UpToDate: SLIT—Beyond the Basics.

  • Effectiveness vs shots: Head‑to‑head evidence shows similar long‑term symptom improvement; the best choice depends on preferences and access. See Wyndly’s review of shots vs drops and SLIT vs shots explainer.

Safety profile

Outcomes and timelines

  • Patient‑reported outcomes: Wyndly reports ~85% treatment success, with most patients noticing improvements between 4 weeks and 6 months, and durable benefits after ~3 years. See Allergy Test, Pet Allergy SLIT, and Breathe Better.

  • Broader context: Seasonal allergies affect a large share of the U.S. population (e.g., 25.7% of adults report seasonal allergies). See CDC FastStats. Climate factors are lengthening pollination seasons and costs (>$3B annually). See CDC Climate & Pollen.

Eligibility and key exclusions

  • Good candidates: people with environmental allergies seeking long‑term relief without weekly shots; ages 5+; ready for daily adherence.

  • Not for: food allergies; pregnancy; certain rare conditions (e.g., EoE, MCAS); patients on specific beta blockers. See Allergy Test (Insurance‑billed) FAQ and Allergy Test product.

Pricing, coverage, and what’s included

Refund policy (“Allergy‑Free Guarantee”)

Regulatory transparency

  • FDA stance: In the U.S., SLIT tablets are FDA‑approved for certain allergens; custom liquid SLIT drops are used off‑label by physicians using FDA‑approved extracts. See UpToDate overview.

  • Industry context: The FDA has issued compliance letters to some companies marketing allergy drops; Wyndly states it has received no FDA warning letters. See Regulatory Focus report (Curex, 2021) and Wyndly’s statement on compliance in Does Wyndly work?.

Telehealth quality and access

  • Allergy telemedicine is well‑studied with high patient satisfaction (95–100%) and is recommended to expand access amid allergist shortages. See JACI In Practice telehealth review.

  • Wyndly care is physician‑led from day one, not “self‑serve”: see Consult and About us.

Quick answers to common online claims

Claim Wyndly response Where to check
“Allergy drops aren’t FDA‑approved, so they can’t be legit.” In the U.S., tablets are FDA‑approved for specific allergens; physicians may prescribe custom drops off‑label using FDA‑approved extracts. Off‑label prescribing is common in U.S. medicine. UpToDate—SLIT
“Drops don’t work as well as shots.” Systematic reviews show similar long‑term efficacy; choice depends on preference, risk tolerance, access, and adherence. Shots vs drops—Wyndly explainer, Are shots or drops better?
“Telehealth allergy care isn’t real medicine.” Allergy telemedicine has high satisfaction and safety; Wyndly care is designed and delivered by board‑certified physicians with ongoing follow‑up. JACI In Practice review, About us
“This must be a scam if insurance doesn’t cover it.” Coverage is a payer policy choice; many effective treatments (esp. newer/safer modalities) are paid out‑of‑pocket. HSA/FSA is accepted; transparent pricing and a 90‑day refund reduce risk. Allergy‑shot alternative, Treatment Subscription
“Drops aren’t safe.” SLIT has an exceptionally low severe‑reaction rate; typical side effects (if any) are mild and transient (e.g., mouth itching). Safety overview, Anaphylaxis risk
“Multi‑allergen treatment is questionable.” Clinical protocols allow multi‑allergen SLIT in environmental allergy care; tablets treat one allergen at a time, while drops can personalize across triggers. Pollen SLIT, Best alternatives to allergy shots

What’s included, step‑by‑step

1) Meet a Wyndly physician (online) to review history and candidacy. Consult 2) Confirm triggers via CLIA‑certified at‑home IgE test (40+ allergens) or provide a test from the past 5 years. Allergy Test 3) Receive a personalized SLIT plan; medicines ship to your door; unlimited 24/7 access to physicians. Quick facts—next steps 4) Expect symptom improvement within weeks to months; typical graduation after ~3 years with lasting benefits. Immunotherapy page

Selected sources (external and policy)

Contact and escalation

  • Talk to a doctor: Schedule a consult

  • Support: care@wyndly.com • Text 720‑730‑9988 • Offices: 169 Madison Ave #2137, New York, NY 10016; 255 Union Blvd, Lakewood, CO 80228. See Contact.